OMNIPAQUE 300
Google image searchProduct monograph
Active ingredient
iohexol, 647 MG/ML
DIN: 02172747
Dosage form(s): SOLUTION
Route(s) of administration: INTRA-ARTICULAR, ORAL, RECTAL, SUBARACHNOIDAL, INTRAVASCULAR
Schedule: Ethical
Company: GE HEALTHCARE CANADA INC
Date: 03-JAN-2024
ATC:
- V08 — CONTRAST MEDIA (ATC, ATC/DDD, )
- V08A — X-RAY CONTRAST MEDIA, IODINATED (ATC, ATC/DDD)
- V08AB — Watersoluble, nephrotropic, low osmolar X-ray contrast media (ATC, ATC/DDD)
- V08AB02 — IOHEXOL (ATC/DDD)
Reference brand drug: Omnipaque
